LUHUA WANG to Gastrointestinal Neoplasms
This is a "connection" page, showing publications LUHUA WANG has written about Gastrointestinal Neoplasms.
Connection Strength
0.073
-
An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib. Br J Haematol. 2012 Sep; 158(6):739-48.
Score: 0.073